Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
Objective: Pancreatic β-cell failure is central to the development and progression of type 2 diabetes (T2D). The aggregation of human islet amyloid polypeptide (hIAPP) has been associated with pancreatic islet inflammation and dysfunction in T2D. Alpha1-antitrypsin (AAT) is a circulating protease in...
Saved in:
Main Authors: | Júlia Rodríguez-Comas (Author), Juan Moreno-Vedia (Author), Mercè Obach (Author), Carlos Castaño (Author), Sara de Pablo (Author), Gema Alcarraz-Vizán (Author), Daniela Díaz-Catalán (Author), Anna Mestre (Author), Raquel Horrillo (Author), Montserrat Costa (Author), Anna Novials (Author), Joan-Marc Servitja (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BACE2 suppression in mice aggravates the adverse metabolic consequences of an obesogenic diet
by: Daniela Díaz-Catalán, et al.
Published: (2021) -
Alpha-1 Antitrypsin Deficiency: Home Therapy
by: Anna Annunziata, et al.
Published: (2021) -
Alpha 1-antitrypsin retention in an ectopic liver
by: Cathomas Gieri, et al.
Published: (2011) -
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes
by: Noyonika Mukherjee, et al.
Published: (2024) -
Islet amyloid polypeptide does not suppress pancreatic cancer
by: Austin J. Taylor, et al.
Published: (2023)